Stifel Nicolaus analyst Ingrid Rico maintained a Buy rating on B2Gold (BTG – Research Report) today and set a price target of C$6.50. The company’s shares closed last Friday at $2.88.

BTG Pactual initiated coverage of Arcos Dorados (ARCO) with a Buy rating and $10.50 price target Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst ...

Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...

Apr. 1, 2025 — A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team ...

HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ...

ASHBURN, VA, April 2, 2025 (EZ Newswire) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late-stage specialty pharmaceutical company focused on rare and orphan ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

Novo Holdings A/S CEO Kasim Kutay says China has “really moved up the value chain” in healthcare. “We’ve seen many others investing in China because of the leap that they’re taking from ...